AxoGen
AXGN
55.75
-0.60
-1.06%
AxoGen
US · AXGN
#2714 by market cap
Listed 1970
55.75
-0.60
-1.06%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About AxoGen
Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Avive Soft Tissue Membrane, AcroVal Neurosensory and Motor Testing System, and AxoTouch Two-Point Discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
- Founded
- 1977
- CEO
- Mr. Michael J. Dale
- Employees
- 622
- Headquarters
- Alachua, Florida, United States of America
- Fiscal year end
- 12-31
- Website
- axogeninc.com
Company profile
- Exchange
- US
- Symbol
- AXGN
- Market-cap rank
- #2714
- Listing date
- 1970-01-01
- Market cap
- 3.33B
- Float cap
- 3.04B
- Shares out
- 59.73M
- Float shares
- 54.61M
Sectors & themes
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
AxoGen discussion 0 comments